Target intelligence / Profile preview

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta (PIK3CD)

Target
PIK3CD
Molecular classification
Enzyme, Kinase, Phosphotransferase
01

Overview

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta (PIK3CD), also known as p110δ, is a catalytic subunit of class I phosphoinositide 3-kinases (PI3Ks). It plays crucial roles in intracellular signaling pathways, especially within the immune system. PIK3CD encodes the p110δ protein, which forms part of the PI3K delta enzyme complex. This enzyme phosphorylates phosphatidylinositol (PI) and its derivatives to generate phosphatidylinositol (3,4,5)-trisphosphate (PIP3), a second messenger that activates downstream signaling cascades involved in cell growth, survival, proliferation, motility, and morphology. In immune cells—particularly B cells and T cells—p110δ is essential for cell development, proliferation, migration, differentiation, and function. Mutations in *PIK3CD* can lead to immunodeficiency disorders such as activated PI3K-delta syndrome type 1. Because of its central role in immune regulation, p110δ is a promising target for drugs that aim to prevent or treat inflammation, autoimmunity and transplant rejection.

Other names
p110δPI(4)P(2)-dependent kinaseClass IA PI kinase delta
02

Mechanism of action

PI3K-delta inhibitor

03

Biological functions

Cell growthSurvivalProliferationMotilityMorphologyB-cell receptor signalingImmune response
04

Disease associations

ImmunodeficiencyInflammationAutoimmunityTransplant rejection

Beyond the preview

Go deeper on Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta (PIK3CD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta (PIK3CD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call